Hutch News

Hutch News

Stories tagged 'immunotherapy'

Two new grants to fuel metastatic breast cancer research

Drs. Erica Goddard and Mark Headley will use their awards to study how breast cancer cells spread to distant organs – and how to stop them.

Nov. 15, 2018 | By Jake Siegel / Fred Hutch News Service

Two early-career investigators at Fred Hutch have received grants that will fuel their research into metastatic breast cancer: Drs. Erica Goddard and Mark Headley.

View story >


Forbes ’30 Under 30’ lists Hutch immunotherapy researcher Alex Salter

Grad student on short list of young health care influencers

Nov. 14, 2018 | by Susan Keown / Fred Hutch News Service

For his research on cancer immunotherapy, Hutch grad student Alex Salter was named one of the top young health care innovators in the U.S. and Canada.

View story >


5 questions with a cancer immunotherapy expert

Dr. Phil Greenberg to receive high honor for his contributions to the field

Nov. 7, 2018 | By Susan Keown / Fred Hutch News Service

Immune-harnessing treatments are revolutionizing cancer care. Where is the immunotherapy field now, and what's next? Fred Hutch science writer Susan Keown asked someone who would know: Dr. Phil Greenberg.

View story >


Metastatic breast cancer research takes the stage

Advocates, oncologists and researchers share findings, resources and reasons for hope at third annual NW Mets Conference

Oct. 31, 2018 | By Diane Mapes / Fred Hutch News Service

An overview of the third annual Northwest Metastatic and Lobular Breast Cancer Conference, held Oct. 26-27 in Seattle.

View story >


Standard myeloma treatment reveals itself as an immunotherapy

Mouse study shows how transplanting patients’ own healthy blood stem cells can curb cancer, opening door to better treatments

Oct. 9, 2018 | By Susan Keown / Fred Hutch News Service

Despite conventional wisdom, a standard treatment for myeloma — autologous transplant — may be a type of immunotherapy, new research shows.

View story >


Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it

How a new technology solved a mystery and honors one man’s legacy

Sept. 24, 2018 | by Susan Keown / Fred Hutch News Service

Before his aggressive cancer took his life, he donated his tissue samples to research. Now scientists think that new insights from his cells could save lives.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.